Inventor
PRESTA LEONARD G
US163 patents
⚠️ This page may combine multiple inventors who share the name “PRESTA LEONARD G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
47 patentsUS7862817B2Jan 4, 2011
Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
GENENTECH INC126 citations99
US7695936B2Apr 13, 2010
Knobs and holes heteromeric polypeptides
GENENTECH INC817 citations99
US7642228B2Jan 5, 2010
Method for making heteromultimeric polypeptides
GENENTECH INC404 citations99
US7537931B2May 26, 2009
Humanized anti-ERBB2 antibodies and treatment with anti-ERBB2 antibodies
GENENTECH INC83 citations99
US7501122B2Mar 10, 2009
Treatment with anti-ErbB2 antibody combinations
GENENTECH INC76 citations99
US7498030B2Mar 3, 2009
Treatment with anti-ErbB2 antibodies and anti-hormonal compounds
GENENTECH INC69 citations99
US7485302B2Feb 3, 2009
Treatment with anti-ErbB2 antibodies and chemotherapeutic agents
GENENTECH INC109 citations99
US7169901B2Jan 30, 2007
Anti-VEGF antibodies
GENENTECH INC160 citations99
US7060269B1Jun 13, 2006
Anti-VEGF antibodies
GENENTECH INC342 citations99
US6998253B1Feb 14, 2006
Altered polypeptides with increased half-life
GENENTECH INC250 citations99
US6884879B1Apr 26, 2005
Anti-VEGF antibodies
GENENTECH INC623 citations99
US6800738B1Oct 5, 2004
Method for making humanized antibodies
GENENTECH INC274 citations99
US6719971B1Apr 13, 2004
Method for making humanized antibodies
GENENTECH INC393 citations99
US6639055B1Oct 28, 2003
Method for making humanized antibodies
GENENTECH INC523 citations99
US6407213B1Jun 18, 2002
Method for making humanized antibodies
GENENTECH INC2,158 citations99
US6172213B1Jan 9, 2001
Anti-IgE antibodies and method of improving polypeptides
GENENTECH INC155 citations99
US6153189ANov 28, 2000
Human TRK receptors and neurotrophic factor inhibitors
GENENTECH INC165 citations99
US6121022ASep 19, 2000
Altered polypeptides with increased half-life
GENENTECH INC1,223 citations99
US6096871AAug 1, 2000
Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
GENENTECH INC290 citations99
US6054297AApr 25, 2000
Humanized antibodies and methods for making them
GENENTECH INC2,266 citations99
US6037454AMar 14, 2000
Humanized anti-CD11a antibodies
GENENTECH INC183 citations99
US6037453AMar 14, 2000
Immunoglobulin variants
GENENTECH INC180 citations99
US6027927AFeb 22, 2000
Human trk receptors and neurotrophic factor inhibitors
GENENTECH INC137 citations99
US5994511ANov 30, 1999
Anti-IgE antibodies and methods of improving polypeptides
GENENTECH INC210 citations99
US5910574AJun 8, 1999
Human trk receptors and neurotrophic factor inhibitors
GENENTECH INC140 citations99
US5877016AMar 2, 1999
Human trk receptors and neurotrophic factor inhibitors
GENENTECH INC190 citations99
US5869046AFeb 9, 1999
Altered polypeptides with increased half-life
GENENTECH INC2,474 citations99
US5844092ADec 1, 1998
Human TRK receptors and neurotrophic factor inhibitors
GENENTECH INC219 citations99
US5821333AOct 13, 1998
Method for making heteromultimeric polypeptides
GENENTECH INC681 citations99
US5821337AOct 13, 1998
Immunoglobulin variants
GENENTECH INC4,043 citations99
US5807706ASep 15, 1998
Method for making heteromultimeric polypeptides
GENENTECH INC587 citations99
US5747035AMay 5, 1998
Polypeptides with increased half-life for use in treating disorders involving the LFA-1 receptor
GENENTECH INC184 citations99
US5739277AApr 14, 1998
Altered polypeptides with increased half-life
GENENTECH INC980 citations99
US5731168AMar 24, 1998
Method for making heteromultimeric polypeptides
GENENTECH INC2,644 citations99
US7951917B1May 31, 2011
Method for making multispecific antibodies having heteromultimeric and common components
GENENTECH INC186 citations98
US7615383B2Nov 10, 2009
Methods for treating neuropathy by agonist anti-trk-C monoclonal antibodies
GENENTECH INC99 citations98
US7384632B2Jun 10, 2008
Agonist anti-trk-C monoclonal antibodies
GENENTECH INC86 citations98
US7375193B2May 20, 2008
Anti-VEGF antibodies
GENENTECH INC62 citations98
US7364731B2Apr 29, 2008
Polypeptide variants
GENENTECH INC102 citations98
US7365166B2Apr 29, 2008
Anti-VEGF antibodies
GENENTECH INC90 citations98
US7297775B2Nov 20, 2007
Polypeptide variants
GENENTECH INC188 citations98
US7297334B2Nov 20, 2007
Anti-vegf antibodies
GENENTECH INC112 citations98
US7183076B2Feb 27, 2007
Method for making multispecific antibodies having heteromultimeric and common components
GENENTECH INC565 citations98
US6538124B1Mar 25, 2003
Polypeptide variants
GENENTECH INC812 citations98
US6528624B1Mar 4, 2003
Polypeptide variants
GENENTECH INC1,073 citations98
US6329509B1Dec 11, 2001
Anti-IgE antibodies
GENENTECH INC84 citations98
US6194551B1Feb 27, 2001
Polypeptide variants
GENENTECH INC2,953 citations98
PRESTA LEONARD G
2 patentsCARTER PAUL J
1 patentShowing the top 50 of 163 patents by PatentIndex Score.